1 completed, 1 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Terminated 1 |
Follow DPP4 inhibitor: new trials by email Literature Review of DPP4 inhibitor trials Research Report on DPP4 inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient Saxagliptin - Diabetes Mellitus | Phase 4 | Completed | Brigham and Women's Hospital | 72 | 2014-07-01 | 2017-06-23 |
| Fatty Liver Study in Patients With Type II Diabetes DPP4 inhibitor, Pioglitazone, Lantus insulin - Type II Diabetes, Nonalcoholic Fatty Liver | Phase 4 | Terminated | The University of Texas Medical Branch, Galveston | 5 | 2013-05-01 | 2018-07-31 |
Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1)
Brigham and Women's Hospital (1) · The University of Texas Medical Branch, Galveston (1)
United States (2)
Nicola Abate, MD (1) · Rajesh K Garg, MD (1)